Avion Wealth Halozyme Therapeutics, Inc. Transaction History

Avion Wealth

$477 Million
Q4 2025

A detailed history of Avion Wealth transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Avion Wealth holds 7 shares of HALO stock, worth $490. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$490

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2025 Jan 23, 2026	BUY	$64.1 - $74.94 $448 - $524	7 New	7 $0
Q2 2025 Jul 30, 2025	BUY	$47.91 - $70.14 $1,293 - $1,893	27 New	27 $1,000

Others Institutions Holding HALO

# of Institutions

664

Shares Held

126M

Call Options Held

599K

Put Options Held

455K

Black Rock Inc. New York, NY

17.6M
Shares

$1.23 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.6M
Shares

$810 Million
0.01% of portfolio
State Street Corp Boston, MA

5.02M
Shares

$351 Million
0.01% of portfolio
Arrowstreet Capital, Limited Partnership Boston, MA

3.29M
Shares

$230 Million
0.16% of portfolio
Invesco Ltd. Atlanta, GA

3.25M
Shares

$227 Million
0.04% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.75B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.

Account